InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 11.07am 15/11/2024 (20 minute delay)
?
Day | ||||||||
---|---|---|---|---|---|---|---|---|
Open | 0.0¢ | Day High | 0.0¢ | Day Low | 0.0¢ | |||
Daily Volume | 0 |
Bids | Sellers | |||||
---|---|---|---|---|---|---|
Number | Price | Volume | Number | Price | Volume | |
1 | 9.8¢ | 15000 | 1 | 10.5¢ | 9800 |
Directors & Senior Management
Mr. Andrew Bursill | Company Secretary |
Mr. Andrew Dutton | Non-Executive Chairman of the Board |
Ms. Jennifer Maritz | Director |
Mr. Alec Bashinsky | Non-Executive Director |
Ms. Pamela Cass | Non-Executive Director |
Data source: Refinitiv